Crowdfunding triggers Capital Increase of 800,000 Euros at Rodos Biotarget
First, impact investing in the area of health economy will be opened up also for private investors within their bounds of possibilities. Second, the company wants to access business partners, collaborators, customers, and private equity through the level of attention created by crowdfunding. This has been achieved with the company entry of medical entrepreneur Otto H. Gies.
This financing round is further accompanied by High-Tech Gründerfonds and Hannover Investimpuls Fonds.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.